MTL-CEBPA, a Small Activating RNA Therapeutic Up-Regulating C/EBP-α, in Patients With Advanced Liver Cancer: A First-In-Human, Multi-Centre, Open-Label, Phase I Trial

Yuk Ting Ma

MTL-CEBPA, a Small Activating RNA Therapeutic Up-Regulating C/EBP-α, in Patients With Advanced Liver Cancer: A First-In-Human, Multi-Centre, Open-Label, Phase I Trial

Immunology and Immunotherapy

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Clinical Cancer Research
Publication status	Published - May 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{a10b3bc3b7bb487783bdf7262832f13e,

title = "MTL-CEBPA, a Small Activating RNA Therapeutic Up-Regulating C/EBP-α, in Patients With Advanced Liver Cancer: A First-In-Human, Multi-Centre, Open-Label, Phase I Trial",

author = "Ma, {Yuk Ting}",

year = "2020",

month = may,

language = "English",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

}